Showing 20 of 20 recruiting trials for “Autosomal dominant polycystic kidney disease”
Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
RecruitingNCT06970028 ↗
Somatosensory Phenotyping of ADPKD
RecruitingNCT07260071 ↗
Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
👨⚕️ Manish Sinha, PhD, MRCP (UK), MRCPCH, King's College London📍 1 site📅 Started Aug 2025View details ↗
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
👨⚕️ Prof. dr. R.T. Gansevoort, University Medical Center Groningen📍 12 sites📅 Started Jul 2024View details ↗
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
👨⚕️ Andrew Mallett, MBBS, PhD, Townsville University Hospital📍 49 sites📅 Started Nov 2022View details ↗
RecruitingNCT06759142 ↗
Analysis of Patients With Autosomal Dominant Polycystic Kidney
👨⚕️ Gaetano La Manna, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Feb 2021View details ↗
RecruitingNCT04630613 ↗
NOX4 and Related Biomarkers in ADPKD
RecruitingNCT04338048 ↗
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
👨⚕️ Lisa Guay-Woodford, MD, Children's Hospital of Philadelphia📍 4 sites📅 Started Oct 2019View details ↗
RecruitingNCT04344769 ↗
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
👨⚕️ Maria V. Irazabal, M.D., Ph.D, Mayo Translational PKD Center, Mayo Clinic📍 1 site📅 Started Oct 2019View details ↗
Enrolling by InvitationNCT03901521 ↗
Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
👨⚕️ Priya Velu, MD, PhD, Weill Medical College of Cornell University📍 1 site📅 Started Jun 2018View details ↗
RecruitingNCT02497521 ↗
The German ADPKD Tolvaptan Treatment Registry
👨⚕️ Thomas Benzing, MD, Prof., University Hospital of Cologne📍 12 sites📅 Started Nov 2015View details ↗
RecruitingNCT06416761 ↗
Genetics in the Progression of Nephropathies
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →